Cargando…

Cardiovascular and cancer events in hyper-high-density lipoprotein cholesterolemic patients: a post hoc analysis of the MEGA study

BACKGROUND: The prognosis for hyper-high-density lipoprotein (HDL) cholesterolemic patients has not been fully elucidated. We conducted a post hoc analysis of MEGA study data to investigate prospectively the incidence of cardiovascular events and cancer in hyper-HDL cholesterolemic patients. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamura, Haruo, Mizuno, Kyoichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246450/ https://www.ncbi.nlm.nih.gov/pubmed/25135178 http://dx.doi.org/10.1186/1476-511X-13-133

Ejemplares similares

Changes in High-Density Lipoprotein Cholesterol and Risks of Cardiovascular Events: A Post Hoc Analysis from the PICASSO Trial
por: Lee, Eun-Jae, et al.
Publicado: (2020)

Ameliorative effect of ethanolic extract of Carica papaya leaves on hyper-cholesterolemic rats: The egg yolk induced model
por: Ademuyiwa, Oluwaseun Hannah, et al.
Publicado: (2023)

Multitendon xanthomatosis in a normo-cholesterolemic patient
por: Gould, Elaine S., et al.
Publicado: (2015)

Management of Elevated Cholesterol in the primary prevention Group of Adult Japanese (MEGA) Study assists the view that a fasting plasma glucose level ≥100 mg/dL increases cardiovascular risk
por: Tajima, Naoko, et al.
Publicado: (2011)

Aqueous extract of Piper sarmentosum decreases atherosclerotic lesions in high cholesterolemic experimental rabbits
por: Amran, Adel A, et al.
Publicado: (2010)

A review on hypo-cholesterolemic activity of Nigella sativa seeds and its extracts
por: Uma Maheswari, Karmegam, et al.
Publicado: (2022)

Association of Hyper-Low-Density Lipoprotein and Hypo-High-Density Lipoprotein Cholesterolemia with Low Saliva Flow Rates in Japanese Community-Dwelling Elders
por: Mizoguchi, Nana, et al.
Publicado: (2022)

Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis
por: Honda, Hirokazu, et al.
Publicado: (2017)

High altitude, hyper-arid soils of the Central-Andes harbor mega-diverse communities of actinobacteria
por: Bull, Alan T., et al.
Publicado: (2017)

High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey
por: Ono, Shin, et al.
Publicado: (2018)

Effects of apple juice on risk factors of lipid profile, inflammation and coagulation, endothelial markers and atherosclerotic lesions in high cholesterolemic rabbits
por: Setorki, Mahbubeh, et al.
Publicado: (2009)

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
por: Willeit, Peter, et al.
Publicado: (2020)

High-Density Lipoproteins in Non-Cardiovascular Diseases
por: Zanotti, Ilaria
Publicado: (2022)

Consumption of a Diet Rich in Cottonseed Oil (CSO) Lowers Total and LDL Cholesterol in Normo-Cholesterolemic Subjects
por: Davis, Kathleen E., et al.
Publicado: (2012)

Relation between high density lipoprotein particles concentration and cardiovascular events: a meta-analysis
por: Wu, YuJing, et al.
Publicado: (2018)

Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants
por: Kim, Hye Jun, et al.
Publicado: (2023)

High density lipoproteins-based therapies for cardiovascular disease
por: Gao, Xuan, et al.
Publicado: (2010)

Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research
por: Kornmueller, Karin, et al.
Publicado: (2019)

Ratio of triglyceride to high-density lipoprotein cholesterol and risk of major cardiovascular events in kidney transplant recipients
por: Kim, Ji Eun, et al.
Publicado: (2019)

Overtourism and support for sports mega events
por: Schnitzer, Martin, et al.
Publicado: (2021)

High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad and the Future
por: Julve, Josep, et al.
Publicado: (2021)

High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future
por: Julve, Josep, et al.
Publicado: (2021)

Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio as Predictor of First Acute Myocardial Infarction and Major Adverse Cardiovascular Event after Intervention in Young Males
por: Li, Zhao, et al.
Publicado: (2018)

Residual Risk of Atherosclerotic Cardiovascular Events in Relation to Reductions in Very‐Low‐Density Lipoproteins
por: Lawler, Patrick R., et al.
Publicado: (2017)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016)

High‐density lipoprotein cholesterol levels are associated with major adverse cardiovascular events in male but not female patients with hypertension
por: Wang, Xiaopu, et al.
Publicado: (2021)

High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis
por: Duprez, Daniel A, et al.
Publicado: (2015)

Corrigendum: Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio as Predictor of First Acute Myocardial Infarction and Major Adverse Cardiovascular Event after Intervention in Young Males
Publicado: (2018)

TBL2 methylation is associated with hyper-low-density lipoprotein cholesterolemia: a case-control study
por: Li, Yang, et al.
Publicado: (2020)

Differing Nutrient Intake and Dietary Patterns According to the Presence of Hyper-Low-Density Lipoprotein Cholesterolemia or Hypertriglyceridemia
por: Kwon, Yu-Jin, et al.
Publicado: (2021)

MEGA: Monte Carlo event generator adaptor
por: Anselmo, F., et al.
Publicado: (1991)

Sports mega-events and changing world order
por: Black, David R.
Publicado: (2023)

Mega grid for mega science
por: Walz, Martha
Publicado: (2006)

High Density Lipoprotein Cholesterol Increasing Therapy: The Unmet Cardiovascular Need
por: Cimmino, Giovanni, et al.
Publicado: (2014)

Study on the value of small dense low‐density lipoprotein in predicting cardiovascular and cerebrovascular events in the high‐risk stroke population
por: Shi, Hanlu, et al.
Publicado: (2022)

High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk
por: Hafiane, Anouar, et al.
Publicado: (2015)

Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease
por: Estrada-Luna, Diego, et al.
Publicado: (2018)

PON1 concentration and high-density lipoprotein characteristics as cardiovascular biomarkers
por: González, Fátima E. Murillo, et al.
Publicado: (2019)

High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future II
por: Julve, Josep, et al.
Publicado: (2022)

Anti-high-density lipoprotein antibodies and lipoprotein characteristics in systemic lupus erythematosus-related cardiovascular disease
por: Su, J, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_h4idoqa3uaa3qso47q8l31ie3s